Expedition Therapeutics $165M Sales Trigger
Expedition Therapeutics just closed a $165M Series A. Time to pitch CTMS. Grab CEO Yi Larsonโs email, core pain points & next-touch checklist to close fast.
Published on
Do not index
Do not index
๐ Battle Card: Expedition Therapeutics
Quick trigger:
ย
๐ค Decision Maker in the News
- Yi Larson, CEO ๐ง <yi.larson@expeditiontx.com>
ย
๐ก Why It Matters
- Fresh capital means ramping up clinical development and in-licensing processes fast to stay ahead. โ Source
ย
๐ฏ Core Pain Point
- Scaling complex clinical operations for EXPD-101 across global sites
- Meeting regulatory compliance in a high-stakes, post-Series A environment
ย
๐ฐ What to Pitch
- Primary: Clinical Trial Management System โ Accelerate IND filings and patient enrollment
- Expansion: Regulatory Compliance & Data Analytics Suite โ Streamline submissions and reduce audit risks
ย
๐บ๏ธ Quick Context
- HQ: San Francisco, CA
- Employees: โ 150
- Rev: โ $0 (pre-revenue)
ย
๐คผ Competitive Intel
Which other vendors youโll probably face to win Expedition Therapeuticsโs business.
ย
- Medidata (medidata.com) โ CTMS / eCOA
- Unique edge: Deep pharma integration
- Evaluated by Head of Clinical Ops
- Veeva Systems (veeva.com) โ Vault CTMS / QMS
- Unique edge: End-to-end regulatory vault
- Evaluated by VP Regulatory Affairs
- Oracle Health Sciences (oracle.com) โ Integrated trial solutions
- Unique edge: Robust global scalability
- Evaluated by CIO for data security
- Benchling (benchling.com) โ R&D informatics
- Unique edge: Lab-to-clinic data sync
- Evaluated by Head of Translational Science
- IQVIA (iqvia.com) โ CRO / analytics
- Unique edge: Real-world evidence capabilities
- Evaluated by VP Strategy
ย
โ Do-Now Checklist
Reference the $165M Series A as the Expedition Therapeutics sales trigger in your outreach
Schedule personalized demos of CTMS and regulatory suite (Day 3 & Day 10)
ย
Next Step
Get these Expedition Therapeutics sales trigger insightsโno fluff, all pipeline.
Subscribe to NewsletterForLeads
ย
๐ง Copy My Prompt for Personalized Cold Outreach
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
โ๏ธ YOUR COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
OUR_COMPANY = โ<your company>โ
OFFER_BRIEF = โClinical Trial Management System to accelerate IND filings and patient enrollmentโ
PROOF_METRIC = โโ TBDโ
CTA_STYLE = โquick_callโ
TONE = โfriendlyโ
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
๐ TARGET COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
NAME = Yi
COMPANY = Expedition Therapeutics
DEPT = Clinical Operations
SIZE = 150
BOTTLENECK = scaling complex clinical operations
EVENT = Oversubscribed $165M Series A Financing
DETAIL = Fresh capital raises
PAIN = scaling complex clinical operations
SRC = https://vcnewsdaily.com/expedition-therapeutics/venture-capital-funding/xrgmjmgjjm
SIM_CO = โ TBD
WIN_METRIC = โ TBD
NEXT_SIZE = โ TBD
EMP_EST = โ 150
REV_EST = โ $0M
โโโโโโโโโโโโโโโโโโโโโโโโ
TASK FOR CHATGPT
โโโโโโโโโโโโโโโโโโโโโโโโ
Role: โNewsletterForLeads SDR-Assistโ
Validate any โ guesses via SRC
EMAIL (keep breaks):
Subject: 150-person Clinical Operations
Yiโnoticed your Clinical Operations team is โ 150.
Thatโs when scaling complex clinical operations slows growth.
We helped โ TBD fix this with Clinical Trial Management System to accelerate IND filings and patient enrollment.
Result: โ TBD.
Quick call?
PSโnext bottleneck hits โ TBD.
DM โค45 words, TONE:
Saw your post about Fresh capital raises โ scaling complex clinical operations.
Clinical Trial Management System to accelerate IND filings and patient enrollment. โ TBD.
Quick chat?